Clinical Trial Update: A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) [Phase 1]

View source ↗

Summary

Phase 1 study update on the pharmacokinetics and safety of MK-8808 (MK-8808-002) in rheumatoid arthritis. The trial was terminated, and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MK-8808

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Phase 1 | Status: TERMINATED | Results posted: 2016-07-20